InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: None

Tuesday, 11/17/2020 9:33:31 AM

Tuesday, November 17, 2020 9:33:31 AM

Post# of 402865
Expecting IPIX to commence launch of Clinical Human Trials in Eastern Europe ...by end of November or first week in December with feedback on preliminary results very quickly...

wsbc cites Russia as the "Overseas" country and with IPIX (predecessor - B- Absssi trials)having past trials there, I would strongly concur...

If Russia, I would not be surprised we get "approval" shortly after 90(+) (-) patient trial is completed. The $ to be made is not the important factor...It prompts regulatory agencies from other countries to review and look seriously at Brilacidin for regulatory review and approval (including FDA).

Russia likely chosen for being both more responsive (if Putin wants it Putin gets it) and a quicker regulatory review /approval process and much less expensive than U.S. trials. (if the Hospitals charge at all...since they are in such a crises)

As per PR...balance of Clinical trials will be in U.S for seeking FDA approval
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News